At Janssen Pharmaceutical Companies of Johnson & Johnson, we are working towards a new era for pulmonary hypertension (PH), aiming to transform the disease into a long-term manageable condition so that patients can live a normal life.
Our goal is to help tackle the diagnosis gap that is delaying patient access to the care they need. This means addressing unmet needs across the patient journey, including screening and diagnosis with echocardiography.
Janssen is a proud sponsor of the British Society of Echocardiography (BSE). Please see below a selection of some of the educational projects we have on offer.